These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 6184081)

  • 1. Antithrombic activity of some polysaccharide resins.
    Mauzac M; Aubert N; Jozefonvicz J
    Biomaterials; 1982 Oct; 3(4):221-4. PubMed ID: 6184081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticoagulant activity of dextran derivatives. Part I: Synthesis and characterization.
    Mauzac M; Jozefonvicz J
    Biomaterials; 1984 Sep; 5(5):301-4. PubMed ID: 6207865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticoagulant activity of dextran derivatives. Part II: Mechanism of thrombin inactivation.
    Fischer AM; Mauzac M; Tapon-Bretaudiere J; Jozefonvicz J
    Biomaterials; 1985 May; 6(3):198-202. PubMed ID: 2408688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticoagulant hydrogels derived from crosslinked dextran. Part I: Synthesis, characterization and antithrombic activity.
    Aubert N; Mauzac M; Jozefonvicz J
    Biomaterials; 1987 Jan; 8(1):24-9. PubMed ID: 2435328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticoagulant hydrogels derived from crosslinked dextran. Part II: Mechanism of thrombin inactivation.
    Aubert N; Mauzac M; Gulino D; Jozefonvicz J
    Biomaterials; 1987 Mar; 8(2):100-4. PubMed ID: 2437972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The anticoagulant activity of dextran sulphate. I. An in vitro comparison between the actions of dextran sulphate and heparin on the various stages of blood coagulation.
    FORWELL GD; INGRAM GI
    J Pharm Pharmacol; 1956 Jul; 8(7):530-45. PubMed ID: 13346452
    [No Abstract]   [Full Text] [Related]  

  • 7. Anticoagulant activity of amino acid modified polystyrene resins: influence of the carboxylic acid function.
    Fougnot C; Dupillier MP; Jozefowicz M
    Biomaterials; 1983 Apr; 4(2):101-4. PubMed ID: 6860750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticomplementary activity of dextran derivatives.
    Mauzac M; Maillet F; Jozefonvicz J; Kazatchkine MD
    Biomaterials; 1985 Jan; 6(1):61-3. PubMed ID: 2578830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticoagulant effects of sulphated polysaccharides in normal and antithrombin III-deficient plasmas.
    Kindness G; Long WF; Williamson FB
    Br J Pharmacol; 1980 Aug; 69(4):675-7. PubMed ID: 6159941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of dextran sulphates on thrombin activity.
    Suzuki K; Hashimoto S
    J Clin Pathol; 1979 May; 32(5):439-44. PubMed ID: 469001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heparin-like activity of insoluble sulphonated polystyrene resins. Part I: Influence of the surface density, nature and binding of substituted anionic groups.
    Kanmangne FM; Labarre D; Serne H; Jozefowicz M
    Biomaterials; 1985 Sep; 6(5):297-302. PubMed ID: 4052545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of dextran sulphate on blood coagulation].
    Hiramaru M
    Nihon Ketsueki Gakkai Zasshi; 1970 Oct; 33(5):652-61. PubMed ID: 5535819
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of Sulfation and Molecular Weight on Anticoagulant Activity of Dextran.
    Drozd NN; Logvinova YS; Torlopov MA; Udoratina EV
    Bull Exp Biol Med; 2017 Feb; 162(4):462-465. PubMed ID: 28243911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular weight dependency of the acquired anticomplementary and anticoagulant activities of specifically substituted dextrans.
    Crepon B; Maillet F; Kazatchkine MD; Jozefonvicz J
    Biomaterials; 1987 Jul; 8(4):248-53. PubMed ID: 2444275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antithrombin activity and prolongation of thrombin time; comparative study of heparin and of some synthetic heparinoids].
    BURSTEIN M; GUINAND A
    Arch Int Pharmacodyn Ther; 1955 Jun; 102(1-2):96-104. PubMed ID: 13239250
    [No Abstract]   [Full Text] [Related]  

  • 16. New heparin-like insoluble materials: part II.
    Fougnot C; Jozefowicz M; Samama M; Bara L
    Ann Biomed Eng; 1979; 7(5-6):441-50. PubMed ID: 549503
    [No Abstract]   [Full Text] [Related]  

  • 17. [Dextran in vascular surgery. Basis of physiopharmacology].
    Zaffiri O; Centi R; Mastroianni A; Pecchiari V; Salicone A
    Minerva Anestesiol; 1971 Apr; 37(4):193-6. PubMed ID: 5566171
    [No Abstract]   [Full Text] [Related]  

  • 18. [Dextran and dynamic coagulation].
    Raby C; Bertrand H
    Presse Med (1893); 1969 Nov; 77(49):1819-20. PubMed ID: 5365693
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacological approaches to thrombin regulation.
    Markwardt F
    Ann N Y Acad Sci; 1986; 485():204-14. PubMed ID: 3551729
    [No Abstract]   [Full Text] [Related]  

  • 20. Utility of anticoagulant drugs in vascular thrombosis: electron microscopic and biophysical study.
    Sawyer PN; Stanczewski B; Pomerance A; Stoner G; Srinivasan S
    Surgery; 1973 Aug; 74(2):263-75. PubMed ID: 4717662
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.